The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2008
|
| DOI | 10.1002/14651858.cd001155.pub2 |
| Pubmed ID | |
| Authors |
George A Wells, Ann Cranney, Joan Peterson, Michel Boucher, Beverley Shea, Vivian Welch, Doug Coyle, Peter Tugwell |
| Abstract |
Osteoporosis is an abnormal reduction in bone mass and bone deterioration leading to increased fracture risk. Alendronate belongs to the bisphosphonate class of drugs, which act to inhibit bone resorption by interfering with the activity of osteoclasts. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 20% |
| India | 1 | 20% |
| United Kingdom | 1 | 20% |
| Spain | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 414 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 2 | <1% |
| Spain | 2 | <1% |
| Denmark | 2 | <1% |
| Mexico | 2 | <1% |
| Australia | 1 | <1% |
| Taiwan | 1 | <1% |
| Canada | 1 | <1% |
| China | 1 | <1% |
| Japan | 1 | <1% |
| Other | 2 | <1% |
| Unknown | 399 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 63 | 15% |
| Student > Bachelor | 53 | 13% |
| Researcher | 44 | 11% |
| Student > Ph. D. Student | 33 | 8% |
| Other | 32 | 8% |
| Other | 78 | 19% |
| Unknown | 111 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 198 | 48% |
| Nursing and Health Professions | 16 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 3% |
| Agricultural and Biological Sciences | 11 | 3% |
| Biochemistry, Genetics and Molecular Biology | 6 | 1% |
| Other | 35 | 8% |
| Unknown | 136 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2022.
All research outputs
#3,555,109
of 26,150,873 outputs
Outputs from Cochrane database of systematic reviews
#6,172
of 13,188 outputs
Outputs of similar age
#14,309
of 171,602 outputs
Outputs of similar age from Cochrane database of systematic reviews
#29
of 79 outputs
Altmetric has tracked 26,150,873 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,188 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,602 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.